Literature DB >> 16047092

Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.

Aimee Anido1, Lisa M Carlson, Lisa Taft, Stephanie L Sherman.   

Abstract

Fragile X syndrome (FXS) is primarily due to a repeat expansion mutation found in the FMR1 X-linked gene. We have conducted a qualitative analysis of responses from women concerning their attitudes toward testing for carrier status of the fragile X mutation among reproductive-age women. We obtained responses from focus groups including women with and without FXS in their families. We found the following themes: (1) mothers of children with FXS have difficulty formulating their opinions on population screening because of their unique experiences surrounding their own carrier diagnosis and their relationship with their children with FXS, (2) the motivation for carrier testing and need for information differ by family history of FXS and parental status, and (3) the timing of carrier testing with respect to a woman's life stage dictates whether carrier information will be viewed as beneficial or detrimental. There was evidence that non-carrier women from the general population would be wholly unprepared for positive carrier results. These findings have significant implications for genetic counseling as well as for population screening.

Entities:  

Keywords:  Empirical Approach; Genetics and Reproduction

Mesh:

Substances:

Year:  2005        PMID: 16047092     DOI: 10.1007/s10897-005-1159-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  20 in total

1.  The impact of population based screening for carriers of cystic fibrosis.

Authors:  H Bekker; G Denniss; M Modell; M Bobrow; T Marteau
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

2.  Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range.

Authors:  Amy K Sullivan; Dana C Crawford; Elizabeth H Scott; Mary L Leslie; Stephanie L Sherman
Journal:  Am J Hum Genet       Date:  2002-05-03       Impact factor: 11.025

3.  Longitudinal study of the carrier testing process for fragile X syndrome: perceptions and coping.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2001-01-01

4.  Carrier testing in fragile X syndrome: effect on self-concept.

Authors:  A McConkie-Rosell; G A Spiridigliozzi; J A Sullivan; D V Dawson; A M Lachiewicz
Journal:  Am J Med Genet       Date:  2000-06-19

5.  Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening.

Authors:  E W Clayton; V L Hannig; J P Pfotenhauer; R A Parker; P W Campbell; J A Phillips
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

7.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

8.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

Authors:  Sébastien Jacquemont; Randi J Hagerman; Maureen A Leehey; Deborah A Hall; Richard A Levine; James A Brunberg; Lin Zhang; Tristan Jardini; Louise W Gane; Susan W Harris; Kristin Herman; James Grigsby; Claudia M Greco; Elizabeth Berry-Kravis; Flora Tassone; Paul J Hagerman
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

9.  Tremor, ataxia and dementia in older men may indicate a carrier of the fragile X syndrome.

Authors:  C Rogers; M W Partington; G M Turner
Journal:  Clin Genet       Date:  2003-07       Impact factor: 4.438

Review 10.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

View more
  23 in total

1.  Carrier screening in preconception consultation in primary care.

Authors:  Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2011-12-20

Review 2.  Advanced technologies for the molecular diagnosis of fragile X syndrome.

Authors:  Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2015-10-21       Impact factor: 5.225

3.  "It gives them more options": preferences for preconception genetic carrier screening for fragile X syndrome in primary healthcare.

Authors:  Alison D Archibald; Chriselle L Hickerton; Samantha A Wake; Alice M Jaques; Jonathan Cohen; Sylvia A Metcalfe
Journal:  J Community Genet       Date:  2016-02-03

Review 4.  Can we make assumptions about the psychosocial impact of living as a carrier, based on studies assessing the effects of carrier testing?

Authors:  Celine Lewis; Heather Skirton; Ray Jones
Journal:  J Genet Couns       Date:  2010-09-29       Impact factor: 2.537

5.  Consumers' desire towards current and prospective reproductive genetic testing.

Authors:  Feighanne Hathaway; Esther Burns; Harry Ostrer
Journal:  J Genet Couns       Date:  2009-01-22       Impact factor: 2.537

6.  Longitudinal interviews of couples diagnosed with diminished ovarian reserve undergoing fragile X premutation testing.

Authors:  Lisa M Pastore; Logan B Karns; Karen Ventura; Myra L Clark; Richard H Steeves; Nancy Callanan
Journal:  J Genet Couns       Date:  2013-06-14       Impact factor: 2.537

7.  Extended family impact of genetic testing: the experiences of X-linked carrier grandmothers.

Authors:  Anna Lehmann; Beverley S Speight; Lauren Kerzin-Storrar
Journal:  J Genet Couns       Date:  2011-04-14       Impact factor: 2.537

8.  Newborn screening and cascade testing for FMR1 mutations.

Authors:  Page L Sorensen; Louise W Gane; Mark Yarborough; Randi J Hagerman; Flora Tassone
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

9.  Psychosocial Responses to being Identified as a Balanced Chromosomal Translocation Carrier: a Qualitative Investigation of Parents in Japan.

Authors:  Mikiko Kaneko; Hirofumi Ohashi; Tomoko Takamura; Hiroshi Kawame
Journal:  J Genet Couns       Date:  2015-03-20       Impact factor: 2.537

10.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.